Goldstein: Expect More Litigation After Myriad

June 13 (Bloomberg Law) -- Tom Goldstein, partner at Goldstein & Russell, PC and founder of SCOTUSblog, talks with Bloomberg Law's Lee Pacchia about the United States Supreme Court's decision in the Association for Molecular Pathology v. Myriad Genetics, Inc. case. At issue was whether patents may be granted on parts of the human body. He also explores whether Justice Scalia's concurrence raises doubts whether he believes in molecular biology, and where patent litigation will head in the wake of the decision. Bloomberg Law is a sponsor of SCOTUSblog.

COP21 Climate Conference: What It Means for Markets
48:05 - Michele Giddens, partner and co-founder at Bridges Ventures, and Patrick Armstrong, chief investment officer at Plurimi Investment Managers, discuss the U.N. summit on climate change and what it means for the markets and investments. They speak to Bloomberg's Guy Johnson on "Countdown." (Source: Bloomberg)
  • World Leaders to Negotiate Climate Change Agreement
  • Oil Outlook: Where Will Prices Head Next?
  • A Look at This Week's Key Market Moving Data